Features and Outcomes of Patients With Reactive Arthritis
Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Completed
CT.gov ID
NCT03926429
Collaborator
(none)
58
2
22.9
29
1.3
Study Details
Study Description
Brief Summary
The aim of this study is to assess the incidence and the clinical and therapeutic characteristics of reactive arthritis and to compare them with those of a historical cohort. We hypothesised that improved hygiene together with prevention and treatment of sexually transmitted infections may have decreased the incidence of reactive arthritis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
58 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Bicentre Retrospective Study of Features and Outcomes of Patients With Reactive Arthritis
Actual Study Start Date
:
Feb 1, 2013
Actual Primary Completion Date
:
Dec 31, 2014
Actual Study Completion Date
:
Dec 31, 2014
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Patient with reactive arthritis
|
Other: Standardised data collection
The following variables will be retrospectively assessed by medical record review using a standardised data collection form:demographics; gender, age; family or personal history of spondyloarthritis, psoriasis, uveitis, inflammatory bowel disease; clinical presentation; mono, oligo or polyarthritis, dactylitis, inflammatory joint pain, enthesopathy, axial symptoms, fever, extra-articular manifestations (conjunctivitis, anterior uveitis, circinate balanitis, skin rash); time interval between infection and musculoskeletal manifestations; causal microorganism if known, or triggering event; HLA-B27; radiographic sacroiliitis; treatments and outcomes (complete recovery at one year follow-up, relapse within 6 months after onset, or spondyloarthritis according to the ASAS criteria).
|
Outcome Measures
Primary Outcome Measures
- To determine the incidence of reactive arthritis in patients hospitalised in the rheumatology department [December 2014]
Incidence of reactive arthritis in patients hospitalised in the rheumatology department
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- reactive arthritis diagnosed in one of the two rheumatology departments from Centre Hospitalier Lyon Sud or Besançon
Exclusion Criteria:
- presence of other known causes of arthritis, such as other defined spondyloarthritides, septic arthritis, Lyme disease, microcrystalline arthritis or rheumatoid arthritis
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU de Besançon | Besançon | France | ||
| 2 | Centre Hospitalier Lyon Sud | Pierre-Bénite | France |
Sponsors and Collaborators
- Hospices Civils de Lyon
Investigators
- Principal Investigator: Fabienne COURY-LUCAS, MD, Hospices Civils de Lyon
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT03926429
Other Study ID Numbers:
- FOPRA
First Posted:
Apr 24, 2019
Last Update Posted:
Apr 24, 2019
Last Verified:
Apr 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: